Cryo Cell International Inc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Nov2010 Nov2011 Nov2012 Nov2013 Nov2014 Nov2015 Nov2016 Nov2017 Nov2018 Nov2019 Nov2020 Nov2021 Nov2022 Nov2023 Nov2024
Revenue & cost
Revenue 17.76M17.92M17.97M18.99M20.13M21.09M23.13M25.38M29.22M31.82M31.15M28.88M30.34M31.34M31.99M
Cost of Revenue 4.50M4.40M4.89M5.32M5.63M5.63M5.77M6.72M8.54M10.04M9.66M8.99M8.79M8.39M7.95M
Gross Profit 13.26M13.52M13.08M13.67M14.49M15.46M17.35M18.66M20.68M21.78M21.49M19.90M21.54M22.95M24.04M
Operating items
Depreciation & Amortization - Total 0.54M0.39M0.38M0.38M0.22M0.24M0.23M0.24M0.31M0.30M0.23M0.33M0.33M0.63M
Research & Development 0.13M0.18M0.11M0.04M0.06M0.05M0.05M0.04M0.09M0.03M0.02M0.05M0.38M1.17M1.24M
Selling, General & Administrative 9.49M12.41M14.43M11.37M12.25M12.39M14.72M13.48M15.63M14.89M14.29M14.61M15.58M17.17M18.52M
Other Operating Expenses 4.80M5.06M4.75M5.51M0.94M8.41M-2.25M-1.02M-2.66M11.52M-1.07M9.98M10.01M24.98M8.12M
Operating Expenses 14.42M18.20M19.68M17.29M18.15M18.16M22.69M20.38M24.03M26.75M23.49M24.87M26.31M43.65M28.51M
Operating Income 3.35M-0.28M-1.71M1.70M1.98M2.93M-0.88M5.01M5.19M5.06M7.66M4.02M4.02M-12.30M3.48M
EBIT 3.35M-0.28M-1.71M1.70M1.98M2.93M-0.88M5.01M5.19M5.06M7.66M4.02M4.02M-12.30M3.48M
Non-operating items
Non Operating Investment Income 0.03M-0.01M-0.01M-0.04M0.05M1.08M
Interest & Investment Income 0.03M0.04M0.06M
Other Non Operating Income 0.06M0.05M0.21M0.02M0.30M-0.08M-0.02M0.00M773.0099.000.45M0.12M0.11M
Non Operating Income -1.26M-1.42M-2.55M-1.35M-0.94M-1.96M-2.91M-1.38M-1.57M-1.67M-2.62M-1.41M-0.71M-1.06M-0.68M
Net income details
EBT 2.09M-1.92M-4.42M0.35M1.04M0.97M-2.48M3.62M3.62M3.39M5.04M2.61M3.32M-13.36M2.80M
Tax Provisions -1.56M0.17M1.89M0.17M0.12M-7.16M-1.16M2.07M4.47M2.80M2.42M3.53M1.57M-3.84M2.72M
Profit After Tax 3.46M-2.10M-6.31M0.03M0.55M8.11M-1.32M2.32M-0.85M2.29M3.62M2.08M2.77M-9.52M0.40M
Equity Income -0.18M-0.23M-0.15M-0.15M-0.36M-0.02M
Income from Continuing Operations 3.65M-2.10M-6.31M0.18M0.92M8.13M-1.32M1.55M-0.85M0.59M2.62M-0.92M1.75M-9.52M0.09M
Consolidated Net Income 3.65M-2.10M-6.31M0.18M0.92M8.13M-1.32M1.55M-0.85M0.59M2.62M-0.92M1.75M-9.52M0.09M
Income towards Parent Company 3.65M-2.10M-6.31M0.18M0.92M8.13M-1.32M1.55M-0.85M0.59M2.62M-0.92M1.75M-9.52M0.09M
Net Income towards Common Stockholders 3.65M-2.10M-6.31M0.18M0.92M8.13M-1.32M1.55M-0.85M0.59M2.62M-0.92M1.75M-9.52M0.09M
Additional items
EPS (Basic) 0.29-0.18-0.560.020.050.85-0.160.33-0.110.290.480.260.33-1.140.05
EPS (Weighted Average and Diluted) 0.29-0.18-0.560.050.83-0.160.30-0.110.270.450.250.33-1.140.05
Shares Outstanding (Weighted Average) 11.75M11.76M11.15M10.76M9.76M8.96M6.80M7.10M7.80M7.80M7.55M8.53M8.52M8.29M8.06M
Shares Outstanding (Diluted Average) 11.81M11.76M11.31M7.46M8.41M
EBITDA 3.35M0.26M-1.32M2.08M0.55M8.28M-1.46M2.32M-0.55M2.29M7.97M4.25M4.36M-11.98M4.11M
Interest Expenses 1.28M1.46M1.02M1.40M1.15M1.30M0.95M1.30M1.55M1.70M1.54M1.38M1.52M1.24M1.86M
Tax Rate 48.30%11.88%46.75%57.23%82.59%48.08%47.39%28.75%96.89%